MYnd Analytics Adds Experienced Sales & Marketing Executive
August 04, 2017 10:10 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Aug. 04, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive medicine company which brings objective physical findings to psychiatric treatment in order...
Tempus Selected by University of Virginia As Partner for Large Granular Lymphocyte Leukemia Research Project
August 03, 2017 10:00 ET
|
Tempus
CHICAGO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and integrating molecular and clinical data, and the...
Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
July 27, 2017 16:05 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop...
Combination of Bionano Genomics and 10x Genomics data produces high quality mammalian genome at low cost
July 25, 2017 08:00 ET
|
BioNano Genomics
SAN DIEGO and BETHESDA, Md., July 25, 2017 (GLOBE NEWSWIRE) -- NCBI, the National Center for Biotechnology Information, has released the annotated genome assembly of the monk seal, Neomonachus...
Esoteric Testing Market worth over $35 billion by 2024: Global Market Insights, Inc.
July 24, 2017 05:30 ET
|
Global Market Insights, Inc
Ocean View, Delaware, July 24, 2017 (GLOBE NEWSWIRE) -- The Industry Growth report “Esoteric Testing Market By Test Type (Endocrinology, Infectious Disease & Immunology, Oncology,...
NASDAQ Listed MYnd Analytics Inc. Announces Closing of $8.79 Million Public Offering
July 19, 2017 12:41 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., July 19, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive analytics company which brings objective physical findings to psychiatric treatment in order...
Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
July 18, 2017 09:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR...
Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform
July 18, 2017 08:00 ET
|
Pacific Biosciences, Inc.
SAN DIEGO and MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB),...
MYnd Analytics Announces Uplisting to NASDAQ and Pricing of $8.79M Underwritten Offering
July 14, 2017 08:30 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., July 14, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive analytics company which brings objective physical findings to psychiatric treatment in order...
MYnd Analytics Declares Special Dividend of Common Stock Warrants to all holders of Common Stock as of July 13, 2017
July 13, 2017 19:38 ET
|
MYnd Analytics, Inc.
NEW YORK, July 13, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), announced that it had established July 13, 2017 as the record date for the determination of stockholders entitled to...